Literature DB >> 25450518

Hepatitis C surveillance among youth and young adults in New York City, 2009-2013.

Catharine Prussing1, Katherine Bornschlegel, Sharon Balter.   

Abstract

Increases in prescription opioid misuse, injection drug use, and hepatitis C infections have been reported among youth and young adults in the USA, particularly in rural and suburban areas. To better understand these trends in New York City and to characterize demographics and risk factors among a population who, by virtue of their age, are more likely to be recently infected with hepatitis C, we analyzed routine hepatitis C surveillance data from 2009 to 2013 and investigated a sample of persons 30 and younger newly reported with hepatitis C in 2013. Between 2009 and 2013, 4811 persons 30 and younger were newly reported to the New York City Department of Health and Mental Hygiene with hepatitis C. There were high rates of hepatitis C among persons 30 and younger in several neighborhoods that did not have high rates of hepatitis C among older people. Among 402 hepatitis C cases 30 and younger investigated in 2013, the largest proportion (44 %) were white, non-Hispanic, and the most commonly reported risk factor for hepatitis C was injection drug use, mostly heroin. Hepatitis C prevention and harm reduction efforts in NYC focused on young people should target these populations, and surveillance for hepatitis C among young people should be a priority in urban as well as rural and suburban settings.

Entities:  

Mesh:

Year:  2015        PMID: 25450518      PMCID: PMC4411323          DOI: 10.1007/s11524-014-9920-5

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  28 in total

1.  Illicit use of opioids: is OxyContin a "gateway drug"?

Authors:  Lauretta E Grau; Nabarun Dasgupta; Alison Phinney Harvey; Kevin Irwin; Anthony Givens; Mark L Kinzly; Robert Heimer
Journal:  Am J Addict       Date:  2007 May-Jun

2.  Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas.

Authors:  Sudip Chatterjee; Barbara Tempalski; Enrique R Pouget; Hannah L F Cooper; Charles M Cleland; Samuel R Friedman
Journal:  AIDS Behav       Date:  2011-10

3.  Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention.

Authors:  Kimberly Page; Meghan D Morris; Judith A Hahn; Lisa Maher; Maria Prins
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

Review 4.  A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

5.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

6.  Non-medical use of prescription analgesics: a three-year national longitudinal study.

Authors:  Carol J Boyd; Christian J Teter; Brady T West; Michele Morales; Sean Esteban McCabe
Journal:  J Addict Dis       Date:  2009-07

7.  Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-06       Impact factor: 17.586

Review 8.  Estimating acute viral hepatitis infections from nationally reported cases.

Authors:  R Monina Klevens; Stephen Liu; Henry Roberts; Ruth B Jiles; Scott D Holmberg
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

9.  Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

Authors:  Joseph J Amon; Richard S Garfein; Linda Ahdieh-Grant; Gregory L Armstrong; Lawrence J Ouellet; Mary H Latka; David Vlahov; Steffanie A Strathdee; Sharon M Hudson; Peter Kerndt; Don Des Jarlais; Ian T Williams
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients.

Authors:  Emily McGibbon; Katherine Bornschlegel; Sharon Balter
Journal:  Am J Med       Date:  2013-06-17       Impact factor: 4.965

View more
  11 in total

1.  Disparities in Reportable Communicable Disease Incidence by Census Tract-Level Poverty, New York City, 2006-2013.

Authors:  Sharon K Greene; Alison Levin-Rector; James L Hadler; Annie D Fine
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

2.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

3.  "Not human, dead already": Perceptions and experiences of drug-related stigma among opioid-using young adults from the former Soviet Union living in the U.S.

Authors:  Alana Gunn; Honoria Guarino
Journal:  Int J Drug Policy       Date:  2016-11-14

4.  Increasing Viral Hepatitis Knowledge Among Urban Ethnic Minority Youth: Findings from a Community Based Prevention Intervention.

Authors:  Ijeoma Opara; David T Lardier; Andriana Herrera; Pauline Garcia-Reid; Robert J Reid
Journal:  J Community Health       Date:  2020-04

5.  Drug use in business bathrooms: An exploratory study of manager encounters in New York City.

Authors:  Brett Wolfson-Stofko; Alex S Bennett; Luther Elliott; Ric Curtis
Journal:  Int J Drug Policy       Date:  2016-10-18

6.  The role of social networks and geography on risky injection behaviors of young persons who inject drugs.

Authors:  Basmattee Boodram; Mary-Ellen Mackesy-Amiti; Carl Latkin
Journal:  Drug Alcohol Depend       Date:  2015-07-03       Impact factor: 4.492

7.  Barriers to Treatment Among New York City Residents with Chronic Hepatitis C Virus Infection, 2014.

Authors:  Andrea King; Katherine Bornschlegel; Nirah Johnson; Eric Rude; Fabienne Laraque
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

8.  Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014.

Authors:  Stacy R Tressler; Maria C Del Rosario; Michelle D Kirby; Ashley N Simmons; Melissa A Scott; Sherif Ibrahim; Joseph C Forbi; Hong Thai; Guo-Liang Xia; Meghan Lyman; Melissa G Collier; Priti R Patel; Danae Bixler
Journal:  Infect Control Hosp Epidemiol       Date:  2021-03-01       Impact factor: 6.520

9.  Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.

Authors:  Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka
Journal:  Open Forum Infect Dis       Date:  2016-07-26       Impact factor: 3.835

10.  Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030.

Authors:  Palittiya Sintusek; Kessarin Thanapirom; Piyawat Komolmit; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2022-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.